[
    [
        {
            "time": "2018-09-18",
            "original_text": "【数据揭秘】09月18日 融资客最看好的前20只个股",
            "features": {
                "keywords": [
                    "融资客",
                    "看好",
                    "个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【数据揭秘】09月18日 融资客最看好的前20只个股",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-18",
            "original_text": "医药行业：带量采购祸福相依 危机并存",
            "features": {
                "keywords": [
                    "医药行业",
                    "带量采购",
                    "祸福相依",
                    "危机并存"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业：带量采购祸福相依 危机并存",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-18",
            "original_text": "华东医药：主要产品未被纳入首批带量采购试点清单",
            "features": {
                "keywords": [
                    "华东医药",
                    "主要产品",
                    "未纳入",
                    "带量采购",
                    "试点清单"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药：主要产品未被纳入首批带量采购试点清单",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-18",
            "original_text": "华东医药、山大华特回应：带量采购对公司影响不大",
            "features": {
                "keywords": [
                    "华东医药",
                    "山大华特",
                    "带量采购",
                    "影响不大"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华东医药、山大华特回应：带量采购对公司影响不大",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-18",
            "original_text": "医药生物行业周报: 关注超跌及子行业龙头",
            "features": {
                "keywords": [
                    "医药生物",
                    "超跌",
                    "子行业龙头"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报: 关注超跌及子行业龙头",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-18",
            "original_text": "“大医保”动态跟踪系列报告之三: 带量采购，祸福相依，危机并存",
            "features": {
                "keywords": [
                    "大医保",
                    "动态跟踪",
                    "带量采购",
                    "祸福相依",
                    "危机并存"
                ],
                "sentiment_score": -0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "“大医保”动态跟踪系列报告之三: 带量采购，祸福相依，危机并存",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 9,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]